Learn More
Medchemexpress LLC Glimepiride | 93479-97-1 | 99.9% | C24H34N4O5S | 10 MM * 1 ML

Supplier: Medchemexpress LLC HYB010410MM/1ML
Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. It is for research use only. It has been shown to decrease extracellular Aβ40 and Aβ42 levels, potentially serving as a promising drug for the treatment of AD associated with diabetes. Compared to other sulfonylureas, it is generally associated with a lower risk of hypoglycemia and less weight gain, and may be safer for patients with cardiovascular disease due to its lack of detrimental effects on ischemic preconditioning.
- Medium-to-long acting sulfonylurea anti-diabetic compound
- Lowers blood glucose in rabbits more effectively than glibenclamide
- Associated with lower risk of hypoglycemia and less weight gain
- May be safer for patients with cardiovascular disease
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.